College of Medicine
Cusi Lab
Led by Kenneth Cusi · Medicine
Auto-generated from UF undergraduate research symposium abstracts
What we study
The Cusi Lab studies obesity, diabetes, and fatty liver disease (NAFLD) in humans, focusing on mechanisms and treatments. They explore how obesity and liver fat contribute to diabetes and liver damage, with a key focus on pioglitazone for NAFLD.
What working here is like
- Clinical
- Human participants
- Papers
- 5
Recent papers, explained
- Is MASLD an independent risk factor for micro- and macrovascular complications of diabetes? A critical reappraisal and future directions
2026 · Diabetologia
- Liver Fat Changes in Patients With Type 2 Diabetes by Presence of Genetic Hepatic Steatosis: A Post Hoc Analysis of SURPASS ‐3 MRI
2026 · Liver International
Tests if PNPLA3 I148M allele affects liver fat changes in diabetes patients.
Show 3 more papersShow fewer
- Assessing Strategies to Mitigate the Effect of Age When Using Fibrosis-4 Index to Screen for Metabolic Dysfunction–Associated Steatotic Liver Disease–Related Liver Fibrosis
2026 · Clinical Gastroenterology and Hepatology
- Using Homeostatic Model Assessment of Insulin Resistance to Improve Metabolic Dysfunction-Associated Steatotic Liver Disease Risk Stratification in Individuals with Type 2 Diabetes from Primary Care and Endocrinology Settings
2026 · Endocrine Practice
- Prediabetes and diabetes as drivers of fibrosis in MASLD: roles of obesity, adipose tissue dysfunction and insulin resistance
2026 · Diabetologia
Plain-language summaries are AI-written and reviewed by us; check the paper for details.
How to reach out
Kenneth Cusi hasn't set up this page yet. You can also look them up in the UF directory (search “Kenneth Cusi”).
Are you in this lab?Claim this lab
Open positions
No positions posted right now. Many labs still take undergrads who reach out to them, so see how to get in touch.